Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Drug Delivery
98 Articles Available
1
5
Can't find what you're looking for? Try our
advanced search
.
Restructuring
Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
PR-M11-19-NI-009
Drug Delivery
New Capsule Can Orally Deliver Drugs that Usually Have to be Injected
PR-M10-19-NI-022
Asthma
Asthma Patients in Europe Will Have Access to a Self-Administered Syringe
PAO-M08-19-NI-031
Drug Delivery
Drug Delivery Tech Based on Sea Lamprey Immune System Could Facilitate Treatment of Brain Disorders
PAO-M05-19-NI-030
Research
Nasal Drug Delivery Systems Market Worth $67.99 Billion By 2025: Grand View Research, Inc.
PR-M03-19-NI-025
Oral Insulin
An Innovative Approach to Oral Insulin
PAO-M02-19-NI-010
Licensing
argenx Licenses Halozyme Subcutaneous Delivery Tech
PAO-M02-19-NI-002
Drug Design
Cook Medical Introduces a New Length of Zilver® PTX®
PR-M08-18-NI-087
Collaboration
Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields
PR-M08-18-NI-086
Drug Delivery
Exosomes Explored as New Option in Drug Delivery
PAO-M08-18-NI-008
Announcement
Cook® Regentec Announces First U.S. Clinical Use of Advance® CS Coronary Sinus Infusion Catheter to Deliver a Therapeutic in Heart Failure Patients
PR-M07-18-NI-063
Inhalation
GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
PAO-M05-18-NI-022
OSD Facility Design
Modern OSD Facility Design Considerations for Operational Efficiency and Regulatory Compliance
PAP-Q2-18-CL-012
Fill-Finish Services
Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services
PAP-Q2-18-CL-020
Donation
Grifols Donates Over 25 million International Units of Blood Clotting Factor in 2017
PR-M04-18-NI-70
Drug Delivery
Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting
PR-M04-18-NI-55
Capsules
Overcoming Formulation Challenges with Liquid-fill Capsules
PAP-Q1-18-CL-004
Drug Delivery
Supporting Parenteral Development and Manufacturing with End-to-End Services
PAP-Q1-18-CL-014
Injectables
Meet Chemo CMO: Preferred Partner for Injectables Manufacturing
PAP-Q1-18-CL-015
Lyophilization
Leveraging Lyophilization Development Expertise for Clinical Manufacturing
PAP-Q1-18-CL-008
Serialization
PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements
PAO-M03-18-NI-008
Drug Delivery
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta® (pegfilgrastim)
PR-M03-18-NI-002
Drug Delivery
Safety of Intravenous Administration of Biostar’s Cultured Stem Cells was Proven: No Possibility of Cancer Occurrence from Multiple Infusions
PR-M01-18-NI-022
Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases
PR-M01-18-NI-015
1
5
»
